IGM Biosciences, Inc. (IGMS) NASDAQ

1.18

+0.045(+3.98%)

Updated at May 09 10:25AM

Currency In USD

Valuation

Market Cap369.74M
Enterprise Value388.43M
P/E Ratio-0.35
PEG Ratio-0.03
Price/Sales Ratio25.21
Price/Book Ratio1.42
Enterprise/Revenue32.19
Enterprise/EBITDA-0.43

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-73.09
Operating Margin-77.86

Management Effectiveness

Return On Assets-0.74
Return On Equity-1.91

Income Statement

Revenue2.68M
Revenue/Share0.04
Gross Profit-6.43M
EBITDA-199.47M
Net Income-195.8M
Diluted EPS-3.24

Balance Sheet

Total Cash183.79M
Total Cash/Share3.04
Total Debt45.19M
Total Debt/Equity0.94
Current Ratio5.14
Book Value Per Share0.8

Price History

52-Week Change-88.83
52-Week High22.5
52-Week Low0.92
Moving Average 50 Days1.26
Moving Average 200 Days7.42

Statistics

Average Volume195,103
Shares Outstanding59.78M
% Held by Institutions35.74

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A